![]() |
![]() ![]() |
|
Bone metastases will affect the vast majority of patients with advanced cancer Left untreated, patients with bone metastases are at risk for painful, debilitating bone complications.
Bone metastases may mimic other diseases that involve the skeleton. There are several methods of detection and monitoring for bone metastases. ZOMETA can significantly reduce or delay bone complications from multiple myeloma or bone metastases from prostate, lung, breast or other solid tumors. In multiple myeloma, however, the source of the cancer resides in the bone—unlike solid tumors that metastasize to the bone. Therefore, the etiology and pathology of multiple myeloma―as well as various chemotherapy treatments for multiple myeloma―may deteriorate healthy bone and cause increased morbidity and bone fragility. Continue reading more to find out about bone metastases complications and incidence. |
|
ZOMETA Information
|
ZOMETA Reimbursement
Bone Metastases Assessment & Measurement | InterventionZ Program for Nurses Resources | Important Safety Information | Prescribing Information For Consumers | Site Guide | Contact Us Terms of Use | Privacy Statement | Corporate Site Use of this website is governed by the Terms of Use and Privacy Statement.
Copyright ©2010 Novartis Pharmaceuticals Corporation. All rights reserved. |